Search - tctmd.com

Displaying 301 - 320 of 849

Sort: Relevancy | Date

News Daily News

Bioresorbable Scaffold Performs Well, But Thrombosis Raises Concerns

Todd Neale

July 24, 2014

News Daily News

El Andamiaje Bioabsorbible tiene un Buen Rendimiento aunque Preocupa la Trombosis

Todd Neale

July 24, 2014

News Daily News

Long-term Mortality Worse for Black vs White NSTEMI Patients, Linked with Treatment Discrepancies

July 17, 2014

News Daily News

La Mortalidad a Largo Plazo es Peor en Pacientes NSTEMI de Raza Negra que en Pacientes de Raza Blanca con Discrepancias en el Tratamiento

July 17, 2014

News Industry News

The Medicines Company Receives Market Authorization Renewal for Angiox® (Bivalirudin) from the European Medicines Agency and the European Commission

July 07, 2014

News Daily News

PCI Efficacy Unaffected by HIV Status

Yael L. Maxwell

July 07, 2014

News Daily News

El Estatus del VIH No Influye en la Eficacia de las PCI

Yael L. Maxwell

July 07, 2014

News Daily News

PREVAIL Published: Watchman, Warfarin Show Comparable Stroke Protection in A-fib

July 03, 2014

News Daily News

Post-AMI Ischemic Stroke Rates Down, Hemorrhagic Stroke Stable Since 1999

Leah Lawrence

July 03, 2014

News Daily News

PREVAIL Publicado: Watchman y Warfarina Ofrecen Protección Similar Frente a los ACV en Pacientes con FA

July 03, 2014

News Daily News

Los Índices de ACV Isquémicos Post-AMI Bajan y los de ACV Hemorrágicos se Mantienen Estables desde 1999

Leah Lawrence

July 03, 2014

News Daily News

CORONOR Registry: No Advantage to Prolonged DAPT in Stable CAD

July 02, 2014

News Daily News

Study of STEMI Care in China Exposes Crucial Treatment Gaps

L.A. McKeown

June 27, 2014

News Daily News

High-Dose Edoxaban as Effective as Warfarin for Stroke Prevention in A-fib

Yael L. Maxwell

June 27, 2014

News Daily News

Un Estudio sobre el Manejo de Cuadros de STEMI en China Desvela Carencias Importantes en el Tratamiento

L.A. McKeown

June 27, 2014

News Daily News

La Dosis Alta de Edoxaban es Igual de Eficaz que la Warfarina en la Prevención de ACV por FA

Yael L. Maxwell

June 27, 2014

News Daily News

Prasugrel Efficacy in STEMI Largely Unaffected by PCI Timing

Yael L. Maxwell

June 17, 2014

News Daily News

PROSPECT Substudy: Persistently High CRP Predicts Future MACE in ACS Patients After PCI

June 04, 2014

News Conference News EuroPCR 2014

Benefit of LAA Closure Becomes Most Evident After 1 Year

Caitlin E. Cox

May 23, 2014

News Industry News

Data on Angiox (Bivalirudin Injection) in Heart Attack Patients Presented at EuroPCR and Published in European Heart Journal

May 22, 2014

Advertisement

Bioresorbable Scaffold Performs Well, But Thrombosis Raises Concerns

El Andamiaje Bioabsorbible tiene un Buen Rendimiento aunque Preocupa la Trombosis

Long-term Mortality Worse for Black vs White NSTEMI Patients, Linked with Treatment Discrepancies

La Mortalidad a Largo Plazo es Peor en Pacientes NSTEMI de Raza Negra que en Pacientes de Raza Blanca con Discrepancias en el Tratamiento

The Medicines Company Receives Market Authorization Renewal for Angiox® (Bivalirudin) from the European Medicines Agency and the European Commission

PCI Efficacy Unaffected by HIV Status

El Estatus del VIH No Influye en la Eficacia de las PCI

PREVAIL Published: Watchman, Warfarin Show Comparable Stroke Protection in A-fib

Post-AMI Ischemic Stroke Rates Down, Hemorrhagic Stroke Stable Since 1999

PREVAIL Publicado: Watchman y Warfarina Ofrecen Protección Similar Frente a los ACV en Pacientes con FA

Los Índices de ACV Isquémicos Post-AMI Bajan y los de ACV Hemorrágicos se Mantienen Estables desde 1999

CORONOR Registry: No Advantage to Prolonged DAPT in Stable CAD

Study of STEMI Care in China Exposes Crucial Treatment Gaps

High-Dose Edoxaban as Effective as Warfarin for Stroke Prevention in A-fib

Un Estudio sobre el Manejo de Cuadros de STEMI en China Desvela Carencias Importantes en el Tratamiento

La Dosis Alta de Edoxaban es Igual de Eficaz que la Warfarina en la Prevención de ACV por FA

Prasugrel Efficacy in STEMI Largely Unaffected by PCI Timing

PROSPECT Substudy: Persistently High CRP Predicts Future MACE in ACS Patients After PCI

Benefit of LAA Closure Becomes Most Evident After 1 Year

Data on Angiox (Bivalirudin Injection) in Heart Attack Patients Presented at EuroPCR and Published in European Heart Journal

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content